Serum Concentrations of Cotinine and Trans-3'-Hydroxycotinine in US Adults: Results From Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health Study.
Connie S SosnoffKevin CaronJ Ricky AkinsKristin DortchRonald E HunterBrittany N PineJune FengBenjamin C BlountYao LiDana M van BemmelHeather L KimmelKathryn C EdwardsMaciej L GoniewiczDorothy K HatsukamiB Rey de CastroJohn T BernertStephen ArnsteinNicolette BorekYing Deng-BryantElena MishinaCharlie LawrenceAndrew HylandStephen S HechtKevin P ConwayJames L PirkleLanqing WangPublished in: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco (2022)
This report summarizes the serum nicotine biomarker measurements in Wave 1 of the PATH Study. We are reporting the first estimates of HCT in serum for daily tobacco users and nonusers in the noninstitutionalized, civilian US adult population; the first nationally representative serum COT estimates for daily exclusive users of different tobacco products and daily polyusers; and the first nationally representative estimate of the serum NMR in daily tobacco users by age, race/ethnicity, and sex.